20 June 2013
Keywords: smithkline, copromote, alcar, beecham, sigma-tau, spa, announced
Article | 29 June 1992
SmithKline Beecham and Sigma-Tau SpA have announced an agreement to copromote Alcar (acetyl-L-carnitine), a treatment for degenerative disorders of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.